New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareKisspeptin-10 vs Adipotide

Kisspeptin-10 vs Adipotide

Side-by-side comparison of key properties, dosing, and research.

Sexual Health & LibidoAnti-Aging & Longevity
Kisspeptin-10
Fat Loss & Metabolic
Adipotide
Summary
Kisspeptin-10 is the biologically active C-terminal decapeptide of kisspeptin, an endogenous regulator of the reproductive axis. It acts upstream of GnRH to potently stimulate LH and testosterone release, and plays a key role in sexual arousal and libido.
Adipotide (FTPP) is a chimeric proapoptotic peptide that selectively targets and destroys blood vessels feeding white adipose tissue. It binds prohibitin on the vasculature of fat tissue, delivering a proapoptotic sequence that induces cell death in fat-specific blood vessels, causing targeted fat tissue regression.
Half-Life
~4 minutes (rapidly degraded); longer-acting analogs like TAK-448 are in development
Estimated 2-4 hours
Admin Route
SubQ, IV
Subcutaneous, Intravenous (research)
Research
Typical Dose
50–500 mcg
Not established for humans; primate studies used 0.1-1 mg/kg
Frequency
Once daily to every other day
Daily for 4 weeks (research protocol)
Key Benefits
  • Potently stimulates LH and testosterone
  • Enhances sexual arousal and libido
  • Activates HPG axis — upstream of GnRH
  • May improve fertility in hypogonadotropic hypogonadism
  • Increases brain activation in sexual attraction circuits
  • May restore LH pulsatility in suppressed HPG axis
  • Targeted reduction of white adipose tissue
  • Promotes fat vasculature apoptosis without systemic toxicity
  • Demonstrated significant fat loss in primate studies
  • Potential for visceral and subcutaneous fat reduction
  • Novel non-hormonal mechanism distinct from GLP-1 agonists
  • Explored for obesity and metabolic syndrome
Side Effects
  • Injection site reactions
  • Temporary nausea
  • Flushing
  • Elevated LH/testosterone (intended effect)
  • +1 more
  • Renal toxicity observed in primate studies (transient, dose-dependent)
  • Dehydration and electrolyte imbalances in research
  • Weight regain upon cessation
  • Limited human data; side effect profile largely from animal studies
Stacks With